Phillips 66 (PSX) closed down more than -1% after Goldman Sachs downgraded the stock to neutral from buy. Soleno Therapeutics (SLNO) closed up more than +37% after the FDA approved its Vykat ...
Phillips 66 (PSX) is down more than -1% after Goldman Sachs downgraded the stock to neutral from buy. Soleno Therapeutics (SLNO) is up more than +36% after the FDA approved its Vykat extended-release ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果